Sphera Funds Management Ltd. Syndax Pharmaceuticals Inc Transaction History

Sphera Funds Management Ltd.

$382 Million
Q3 2025

A detailed history of Sphera Funds Management Ltd. transactions in Syndax Pharmaceuticals Inc stock. As of the latest transaction made, Sphera Funds Management Ltd. holds 387,716 shares of SNDX stock, worth $6.44 Million. This represents 1.56% of its overall portfolio holdings.

Number of Shares

387,716

Previous 1,571,564 75.33%

Holding current value

$6.44 Million

Previous $14.7 Million 59.48%

% of portfolio

1.56%

Previous 4.05%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 14, 2025	SELL	$8.73 - $17.04 $10.3 Million - $20.2 Million	-1,183,848 Reduced 75.33%	387,716 $5.97 Million
Q2 2025 Aug 14, 2025	SELL	$8.9 - $14.15 $822,449 - $1.31 Million	-92,410 Reduced 5.55%	1,571,564 $14.7 Million
Q1 2025 May 15, 2025	BUY	$12.29 - $16.38 $3.47 Million - $4.63 Million	282,733 Added 20.47%	1,663,974 $20.5 Million
Q4 2024 Feb 14, 2025	BUY	$12.52 - $21.81 $4.34 Million - $7.55 Million	346,395 Added 33.47%	1,381,241 $18.3 Million
Q3 2024 Nov 14, 2024	BUY	$17.93 - $24.81 $3.82 Million - $5.28 Million	212,799 Added 25.89%	1,034,846 $19.9 Million

Q2 2024 Aug 14, 2024	BUY	$18.82 - $23.79 $170,942 - $216,084	9,083 Added 1.12%	822,047 $16.9 Million
Q1 2024 May 15, 2024	BUY	$19.71 - $24.57 $788,400 - $982,800	40,000 Added 5.17%	812,964 $19.3 Million
Q4 2023 Feb 14, 2024	SELL	$11.39 - $21.67 $1,104 - $2,101	-97 Reduced 0.01%	772,964 $16.7 Million
Q3 2023 Nov 14, 2023	BUY	$14.52 - $21.77 $726,000 - $1.09 Million	50,000 Added 6.92%	773,061 $11.2 Million
Q2 2023 Aug 14, 2023	BUY	$19.35 - $22.31 $774,000 - $892,400	40,000 Added 5.86%	723,061 $15.1 Million
Q1 2023 May 15, 2023	SELL	$20.66 - $28.98 $568,150 - $796,950	-27,500 Reduced 3.87%	683,061 $14.4 Million
Q4 2022 Feb 14, 2023	SELL	$20.64 - $26.24 $2.31 Million - $2.94 Million	-112,135 Reduced 13.63%	710,561 $18.1 Million
Q3 2022 Nov 14, 2022	SELL	$18.51 - $24.79 $5.86 Million - $7.85 Million	-316,633 Reduced 27.79%	822,696 $19.8 Million
Q2 2022 Aug 15, 2022	SELL	$13.64 - $19.48 $1.88 Million - $2.69 Million	-138,084 Reduced 10.81%	1,139,329 $21.9 Million
Q1 2022 May 16, 2022	BUY	$14.84 - $22.15 $1.5 Million - $2.23 Million	100,828 Added 8.57%	1,277,413 $22.2 Million
Q4 2021 Feb 14, 2022	BUY	$15.23 - $22.47 $6.49 Million - $9.57 Million	425,982 Added 56.75%	1,176,585 $25.8 Million
Q3 2021 Nov 15, 2021	BUY	$13.87 - $19.8 $2.82 Million - $4.03 Million	203,416 Added 37.17%	750,603 $14.3 Million
Q2 2021 Aug 17, 2021	SELL	$13.42 - $25.18 $1.22 Million - $2.29 Million	-90,906 Reduced 14.25%	547,187 $9.4 Million
Q1 2021 May 17, 2021	SELL	$19.28 - $24.59 $2.08 Million - $2.65 Million	-107,807 Reduced 14.45%	638,093 $14.3 Million
Q4 2020 Feb 16, 2021	BUY	$15.1 - $26.44 $3.56 Million - $6.24 Million	235,900 Added 46.25%	745,900 $16.6 Million
Q3 2020 Nov 12, 2020	BUY	$13.39 - $17.48 $3.88 Million - $5.07 Million	290,000 Added 131.82%	510,000 $7.53 Million
Q2 2020 Aug 13, 2020	BUY	$8.94 - $20.98 $1.36 Million - $3.19 Million	151,866 Added 222.89%	220,000 $3.26 Million
Q1 2020 May 14, 2020	BUY	$6.65 - $12.03 $453,091 - $819,652	68,134 New	68,134 $747,000
Q2 2018 Aug 13, 2018	SELL	$6.93 - $14.63 $2.07 Million - $4.37 Million	-298,472 Closed	0 $0
Q1 2018 May 10, 2018	BUY	$8.71 - $14.82 $435,500 - $741,000	50,000 Added 20.12%	298,472 $4.25 Million
Q3 2017 Nov 09, 2017	BUY	$10.9 - $12.73 $2.71 Million - $3.16 Million	248,472	248,472 $2.91 Million

Others Institutions Holding SNDX

# of Institutions

254

Shares Held

99.9M

Call Options Held

1.41M

Put Options Held

737K

View Full List

About Syndax Pharmaceuticals Inc

Ticker SNDX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,565,200
Market Cap $940M
Description
Syndax Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of cancer. Its lead product candidates are SNDX-5613, which is in phase 1/2 clinical trial targeting the binding interaction of Menin with the mixed lineage leukemia 1 protein for the treatment of MLL-rearranged (MLLr) and nucleophosmin...

More about SNDX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sphera Funds Management Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Sphera Funds Management Ltd. with notifications on news.

Account

Sphera Funds Management Ltd. Syndax Pharmaceuticals Inc Transaction History